Gulf & Middle East · Regional markets · Globes
GrowthCurve Capital buys medication access co TailorMed
The US private equity firm is buying a majority stake in the Israeli startup at a company valuation of $250 million.
Read the full article on Globes Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (en.globes.co.il)
